JP2015531397A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015531397A5 JP2015531397A5 JP2015535742A JP2015535742A JP2015531397A5 JP 2015531397 A5 JP2015531397 A5 JP 2015531397A5 JP 2015535742 A JP2015535742 A JP 2015535742A JP 2015535742 A JP2015535742 A JP 2015535742A JP 2015531397 A5 JP2015531397 A5 JP 2015531397A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- monoclonal antibody
- antibody
- mabp1
- igg1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261709754P | 2012-10-04 | 2012-10-04 | |
| US61/709,754 | 2012-10-04 | ||
| PCT/US2013/062903 WO2014055544A1 (en) | 2012-10-04 | 2013-10-01 | Treating vascular disease and complications thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015531397A JP2015531397A (ja) | 2015-11-02 |
| JP2015531397A5 true JP2015531397A5 (enExample) | 2016-11-17 |
| JP6460993B2 JP6460993B2 (ja) | 2019-01-30 |
Family
ID=50432830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015535742A Active JP6460993B2 (ja) | 2012-10-04 | 2013-10-01 | 血管疾患及びその合併症の処置 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20140099321A1 (enExample) |
| EP (3) | EP2904010A4 (enExample) |
| JP (1) | JP6460993B2 (enExample) |
| KR (2) | KR102429919B1 (enExample) |
| CN (2) | CN113018431A (enExample) |
| AU (1) | AU2013327501B2 (enExample) |
| CA (1) | CA2886747C (enExample) |
| HK (1) | HK1211960A1 (enExample) |
| IL (1) | IL237765B (enExample) |
| MX (1) | MX376241B (enExample) |
| RU (1) | RU2671955C2 (enExample) |
| WO (1) | WO2014055544A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2582391B1 (en) | 2010-06-18 | 2018-10-03 | XBiotech, Inc | Arthritis treatment |
| KR101910760B1 (ko) | 2010-08-23 | 2018-10-22 | 엑스바이오테크, 인크. | 종양성 질병들에 대한 치료 |
| US9724409B2 (en) | 2011-04-01 | 2017-08-08 | Xbiotech, Inc. | Treatment of inflammatory skin disease |
| CN108404127B (zh) | 2011-09-23 | 2025-12-12 | 埃克斯生物科技公司 | 恶病质治疗 |
| US9545441B2 (en) | 2012-09-18 | 2017-01-17 | Xbiotech, Inc. | Treatment of diabetes |
| EP3582813A4 (en) | 2017-02-16 | 2020-12-30 | XBiotech, Inc | TREATMENT OF SUPPURATIVE HIDRADENITIS |
| KR20220019674A (ko) * | 2019-05-03 | 2022-02-17 | 유니베르시태트 취리히 | 뇌 허혈-재관류 손상의 치료 |
| CA3095675A1 (en) | 2020-10-07 | 2022-04-07 | Xbiotech Inc. | True human antibody specific for interleukin 1 alpha (il-1a) |
| CA3095676A1 (en) | 2020-10-07 | 2022-04-07 | Xbiotech Inc. | True human antibody specific for interleukin 1 alpha (il-1a) |
| CA3095740A1 (en) | 2020-10-07 | 2022-04-07 | Xbiotech Inc. | True human antibody specific for interleukin alpha (il-1a) |
| CA3095679A1 (en) | 2020-10-07 | 2022-04-07 | Xbiotech Inc. | True human antibody specific for interleuken 1 alpha (il-1a) |
| KR102652849B1 (ko) | 2022-03-14 | 2024-04-01 | 한국화학연구원 | 극성 아라미드 나노섬유로 제조한 하이드로겔 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| RU2235541C2 (ru) * | 1994-10-04 | 2004-09-10 | Эмори Юниверсити | Лечение атеросклероза и других сердечно-сосудистых и воспалительных заболеваний |
| JP2003500069A (ja) * | 1999-05-24 | 2003-01-07 | インタールーキン ジェネティックス インク | 再狭窄の診断及び治療薬 |
| WO2003018595A2 (en) * | 2001-08-24 | 2003-03-06 | Maine Medical Center Research Institute | Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| US20040224893A1 (en) * | 2003-05-06 | 2004-11-11 | Li-Hsien Wang | Methods of using IL-1 antagonists to treat neointimal hyperplasia |
| EP2285409B1 (en) * | 2008-05-30 | 2016-04-20 | XBiotech, Inc | Il-1 alpha antibodies |
| SG10201500180RA (en) * | 2009-05-29 | 2015-03-30 | Xoma Us Llc | CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF |
| JP5812669B2 (ja) | 2011-04-27 | 2015-11-17 | キヤノン株式会社 | 画像処理装置および画像処理方法およびコンピュータプログラム。 |
-
2013
- 2013-10-01 JP JP2015535742A patent/JP6460993B2/ja active Active
- 2013-10-01 MX MX2015004286A patent/MX376241B/es active IP Right Grant
- 2013-10-01 KR KR1020217027089A patent/KR102429919B1/ko active Active
- 2013-10-01 EP EP13843772.8A patent/EP2904010A4/en not_active Ceased
- 2013-10-01 WO PCT/US2013/062903 patent/WO2014055544A1/en not_active Ceased
- 2013-10-01 HK HK15112832.0A patent/HK1211960A1/xx unknown
- 2013-10-01 KR KR1020157009716A patent/KR102296017B1/ko active Active
- 2013-10-01 EP EP18215704.0A patent/EP3524621A1/en not_active Ceased
- 2013-10-01 AU AU2013327501A patent/AU2013327501B2/en active Active
- 2013-10-01 CA CA2886747A patent/CA2886747C/en active Active
- 2013-10-01 EP EP25187641.3A patent/EP4628162A3/en active Pending
- 2013-10-01 RU RU2015110635A patent/RU2671955C2/ru active
- 2013-10-01 CN CN202110285555.5A patent/CN113018431A/zh active Pending
- 2013-10-01 CN CN201380051667.8A patent/CN104684929A/zh active Pending
- 2013-10-02 US US14/044,418 patent/US20140099321A1/en not_active Abandoned
-
2015
- 2015-03-16 IL IL237765A patent/IL237765B/en active IP Right Grant
-
2017
- 2017-11-01 US US15/800,407 patent/US20180057585A1/en not_active Abandoned
-
2021
- 2021-09-10 US US17/471,702 patent/US20210403548A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015531397A5 (enExample) | ||
| RU2015110635A (ru) | Лечение сосудистого заболевания и его осложнений | |
| CY1122245T1 (el) | Pd-1 αντισωμα, θραυσμα δεσμευσης αντιγονου αυτου, και ιατρικη εφαρμογη αυτου | |
| HUE056217T2 (hu) | Bispecifikus anti-VEGF/anti-ANG-2 antitestek és ezek alkalmazása szemészeti érbetegségek kezelésében | |
| MY198928A (en) | B7-h3 antibody, antigen-binding fragment thereof and medical use thereof | |
| WO2016087944A3 (en) | Method for treating alzheimer's disease | |
| JP2015531396A5 (enExample) | ||
| JP2016519107A5 (enExample) | ||
| JP2013536236A5 (enExample) | ||
| de Carvalho et al. | Recent advances in ophthalmic molecular imaging | |
| Meyr et al. | American College of Foot and Ankle Surgeons® clinical consensus statement: perioperative management | |
| WO2015081283A3 (en) | Long non-coding rna as a diagnostic and therapeutic agent | |
| EP2997992A4 (en) | Mechanism for guiding and/or releasing an endoprosthesis at a blood vessel lesion region, used in a medical device of the type of a cathether | |
| IL272194A (en) | Multispecific antibodies for use in treating diseases | |
| EP2844776A4 (en) | CANCER BLOOD TEST USING INSULATED BC200 RNA FROM PERIPHERAL BLOOD FOR THE DIAGNOSIS AND TREATMENT OF INVASIVE BREAST CANCER | |
| EA201500765A1 (ru) | Способы лечения сердечно-сосудистых заболеваний | |
| JP2013094262A5 (enExample) | ||
| Fabbiani et al. | Ophthalmic artery resistance index is increased in HIV-Infected patients and is influenced by protease inhibitors exposure | |
| Bykov et al. | Syndrome-pathogenetic Postoperational Rehabilitation of Patients with Dishormonal Mastopathy | |
| Bonten | Prof. dr. Y. van der Graaf Julius Center for Health Sciences and Primary Care | |
| Petti | Viewing humans as molecules to improve accuracy of clinical predictions. | |
| CN301978866S (zh) | 低频率治疗器 | |
| 赵玉洲 | Anatomy of splenic flexure and surgical treatment in 52 patients with non-obstructive splenic flexure colon cancer | |
| Pohodenko-Chudakova et al. | BASIS FOR ACUPUNCTURE APPLICATION IN COMPLEX TREATMENT OF PYOINFLAMMATORY PROCESSES ACCORDING TO THE PRINCIPLES OF DEMONSTRATIVE MEDICINE | |
| Pohodenko-Chudakova et al. | BASIS FOR ACUPUNCTURE APPLICATION IN COMPLEX TREATMENT OF PYOINFLAMMATORY PROCESSES ACCORDING TO THE PRINCIPLES OF DEMONSTRATIVE MEDICINE |